Rottapharm Biotech | Innovating Drug Development for Over 50 Years
Skip to content
About Us
Our Approach
Pipeline
News
Contacts
Search for...
Navigation Menu
Navigation Menu
About Us
Our Approach
Pipeline
News
Contacts
Search for...
Our approach
Our business model includes internal products development and external partnership projects, with active participation or strategic investments.
Learn more
Who we are
Discovering and developing novel drugs has been our passion, work and mission for over 50 years. Rottapharm Biotech lives for innovation and innovation lives at Rottapharm Biotech. This is all we are and all we want to be.
Learn more
Latest news
April 11, 2024
News
Rottapharm Biotech announces upcoming oral presentation of CR10049 in the inflammatory osteoarthritis (OA) phenotype at the OARSI World Congress on OA
Read more...
October 23, 2023
News
Rottapharm Biotech discloses at ESMO 2023 favourable results from the Phase 1/2 study of the EP4 receptor antagonist CR6086 combined with the anti-PD-1 balstilimab in advanced colorectal cancer
Read more...
January 11, 2023
Publication
COVID-eVax PHASE 1 CLINICAL TRIAL RESULTS PUBLISHED
Read more...
Rottapharm Biotech S.r.l. is a Company of the Fidim Group.
Head Office
Rottapharm Biotech S.r.l.
Via Valosa di Sopra, 9
20900 – Monza – ITALY
Rottapharm Biotech S.r.l. is a single shareholder Company of the Fidim Group, with Head Office in Via Valosa di Sopra, 9 – 20900 Monza (MB) Italy. Share capital: € 95.922,50; tax and VAT number: 12961590150; listed in the Milan Monza Brianza Lodi Company Register, number: 12961590150; REA number: MB – 1600515.
For the conduct of its business and in the management of its relationships, Rottapharm Biotech S.r.l. refers to and adheres to the
Code of Ethics of Fidim
.
Rottapharm Biotech S.r.l. è una Società a socio unico del Gruppo Fidim, con sede legale in Via Valosa di Sopra, 9 – 20900 Monza (MB) Italia. Capitale sociale: € 95.922,50; C.F. / P. IVA: 12961590150; numero di iscrizione e Ufficio del Registro delle imprese di Milano Monza Brianza Lodi: 12961590150; numero REA: MB – 1600515.
Nella conduzione dei propri affari e nella gestione dei propri rapporti, Rottapharm Biotech S.r.l. si riferisce e aderisce ai principi contenuti nel
Codice Etico e di Condotta di Fidim
.
Copyright 2024 © Rottapharm Biotech - All rights reserved.
Homepage
Privacy Policy
Cookie Policy
Terms of Use
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Statistics
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes
Accept
Deny
View preferences
Save preferences
View preferences
{title}
{title}
{title}
Manage consent